Eloxx Pharmaceuticals Announces Cystic Fibrosis Foundation (CF Foundation) To Provide Funding and Support for ELX-02 U.S. Phase 2 Clinical Trial September 23, 2019 - NASDAQ Companies 0 » View More News for September 23, 2019